top of page

MASS SPECTROMETRY
AND IMMUNOTHERAPY

Immunopeptidomics. Proteomics. Bioinformatics.

PARADIGM SHIFTING SCIENCE

The field of immunopeptidomics will become as transformative as cancer genomics and will revolutionize cancer immunotherapy to improve patient care worldwide. 

​

The Caron Lab moved to Yale University in 2024 to achieve this goal!

PASSION CAN CURE ANYTHING!

WHY WE DO IT

Immunopeptidomics is an emerging interdisciplinary science that has the potential to substantially influence various biomedical research fields, including:

  • T-cell immunology

  • Cancer immunotherapy

  • Vaccine development

  • Autoimmune research

  • Infectious disease research

  • Biomarker discovery

  • Personalized medicine

timstof.jpeg

WHAT WE DO

  • Develop next-generation immunopeptidomics technologies

  • Develop a systems immunopeptidomics framework to challenge the current T-cell activation paradigm

  • Collaborate with clinical investigators and researchers in the field of autoimmunity, infectious diseases and cancer

HOW WE DO IT

  • We apply interdisciplinary methods from the fields of  immunology, biochemistry, analytical chemistry, bioengineering, computational biology, artificial intelligence, and software engineering

  • We foster a culture that embraces inspiration from others

  • We love the Yale community and its outstanding research and collegial environment  

  • We build the dream team

  • We have fun! 

CARONLAB_logo.jpg
bottom of page